COPD Drugs Market

COPD drugs is a medicine used to treatment chronic obstructive pulmonary disease, such as bronchodilators, pde-4 inhibitors? steroids, combination therapies, etc.
COPD Drugs Market contains market size and forecasts of COPD Drugs in Global, including the following market information:
Global COPD Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global COPD Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bronchodilators Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of COPD Drugs include Pfizer, Novartis, GlaxoSmithKline, Merck, Abbott Laboratories, Boehringer Ingelheim, AstraZeneca, Roche Holding AG and Teva Pharmaceutical Industries, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the COPD Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global COPD Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global COPD Drugs Market Segment Percentages, by Type, 2021 (%)
Bronchodilators
PDE-4 Inhibitors
Steroids
Combination Therapies
Others
Global COPD Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global COPD Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global COPD Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global COPD Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies COPD Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies COPD Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
GlaxoSmithKline
Merck
Abbott Laboratories
Boehringer Ingelheim
AstraZeneca
Roche Holding AG
Teva Pharmaceutical Industries
Vectura Group
Mylan NV